News | January 25, 2024
Shilpa Medicare directed to to pay damage to Celltrion
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Inducts advanced AI-Powered 24x7 remote patient monitoring system
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Multi-ethnic innovation helps all complexions appear clearer and more uniform
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
General Medicine grows 5% and Vaccines 10% led by Shingrix
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Subscribe To Our Newsletter & Stay Updated
